2-phthalimidoethanesulfonamide

Also Known As:

MY 103; MY-103

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

1.	Seizures (Absence Seizure) 01/01/1985 - "MY-103 decreased seizure intensity in maximally-responding animals, but was otherwise without effect on sound-induced seizures. " 01/01/1985 - "MY-103, at doses up to 300 mg/kg, was ineffective against guanidinoethane sulfonate-induced seizures. " 01/01/1985 - "The taurine derivatives, 2-phthalimidoethanesulfon-N-isopropylamide (taltrimide) and 2-phthalimidoethanesulfonamide (MY-103), were tested intraperitoneally against genetic and experimentally produced seizures. "
2.	Brain Ischemia (Cerebral Ischemia) 07/01/1984 - "Judged by the degree of recovery of brain electrical activity, five drugs were considered to have protective effect against brain ischemia: mannitol, vitamin E, MY-103, DEXA and Y-9197. "
3.	Brain Hypoxia (Cerebral Hypoxia) 10/01/1980 - "The protective effect of suloctidil [MY 103, erythro-1-(4-isopropylthiophenyl)-2-n-octylaminopropanol] against cerebral hypoxia was investigated in terms of survival time under normobaric hypoxia (96% N2 + 4% O2 gas mixture) in mice and evoked potential in prepyriform cortex of guinea pig in vitro. "
4.	Hypoxia (Hypoxemia) 10/01/1980 - "The protective effect of suloctidil [MY 103, erythro-1-(4-isopropylthiophenyl)-2-n-octylaminopropanol] against cerebral hypoxia was investigated in terms of survival time under normobaric hypoxia (96% N2 + 4% O2 gas mixture) in mice and evoked potential in prepyriform cortex of guinea pig in vitro. "